• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用 RNA 原位杂交技术评估前列腺癌组织 PCA3 表达——与尿 PCA3 和 TMPRSS2-ERG 的相关性研究。

Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization--a correlative study with urine PCA3 and TMPRSS2-ERG.

机构信息

Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.

1] Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA [2] Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA [3] Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA [4] Department of Urology, University of Michigan Medical School, Ann Arbor, MI, USA.

出版信息

Mod Pathol. 2014 Apr;27(4):609-20. doi: 10.1038/modpathol.2013.169. Epub 2013 Sep 27.

DOI:10.1038/modpathol.2013.169
PMID:24072184
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3968238/
Abstract

PCA3 is a prostate-specific non-coding RNA, with utility as a urine-based early detection biomarker. Here, we report the evaluation of tissue PCA3 expression by RNA in situ hybridization in a cohort of 41 mapped prostatectomy specimens. We compared tissue PCA3 expression with tissue level ERG expression and matched pre-prostatectomy urine PCA3 and TMPRSS2-ERG levels. Across 136 slides containing 138 foci of prostate cancer, PCA3 was expressed in 55% of cancer foci and 71% of high-grade prostatic intraepithelial neoplasia foci. Overall, the specificity of tissue PCA3 was >90% for prostate cancer and high-grade prostatic intraepithelial neoplasia combined. Tissue PCA3 cancer expression was not significantly associated with urine PCA3 expression. PCA3 and ERG positivity in cancer foci was positively associated (P<0.01). We report the first comprehensive assessment of PCA3 expression in prostatectomy specimens, and find limited correlation between tissue PCA3 and matched urine in prostate cancer.

摘要

PCA3 是一种前列腺特异性非编码 RNA,可用作基于尿液的早期检测生物标志物。在这里,我们报告了对 41 个映射前列腺切除术标本中的组织 PCA3 表达进行 RNA 原位杂交评估的结果。我们将组织 PCA3 表达与组织水平的 ERG 表达以及匹配的前列腺前尿 PCA3 和 TMPRSS2-ERG 水平进行了比较。在包含 138 个前列腺癌病灶的 136 张幻灯片中,PCA3 在 55%的癌症病灶和 71%的高级别前列腺上皮内瘤变病灶中表达。总体而言,组织 PCA3 对前列腺癌和高级别前列腺上皮内瘤变的特异性>90%。组织 PCA3 癌症表达与尿 PCA3 表达无显著相关性。癌症病灶中 PCA3 和 ERG 的阳性表达呈正相关(P<0.01)。我们报告了前列腺切除术标本中 PCA3 表达的首次全面评估,发现组织 PCA3 与前列腺癌的匹配尿液之间相关性有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bd/3968238/ef4b1b740554/nihms514300f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bd/3968238/d406cee7f47a/nihms514300f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bd/3968238/733e530836fb/nihms514300f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bd/3968238/60ae2b787185/nihms514300f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bd/3968238/eb6107d9bfd7/nihms514300f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bd/3968238/ef4b1b740554/nihms514300f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bd/3968238/d406cee7f47a/nihms514300f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bd/3968238/733e530836fb/nihms514300f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bd/3968238/60ae2b787185/nihms514300f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bd/3968238/eb6107d9bfd7/nihms514300f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bd/3968238/ef4b1b740554/nihms514300f5.jpg

相似文献

1
Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization--a correlative study with urine PCA3 and TMPRSS2-ERG.应用 RNA 原位杂交技术评估前列腺癌组织 PCA3 表达——与尿 PCA3 和 TMPRSS2-ERG 的相关性研究。
Mod Pathol. 2014 Apr;27(4):609-20. doi: 10.1038/modpathol.2013.169. Epub 2013 Sep 27.
2
Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.联合检测尿 TMPRSS2:ERG 和 PCA3 与血清 PSA 预测前列腺癌的诊断。
Urol Oncol. 2013 Jul;31(5):566-71. doi: 10.1016/j.urolonc.2011.04.001. Epub 2011 May 19.
3
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.尿液中TMPRSS2:ERG加PCA3用于个体化前列腺癌风险评估。
Eur Urol. 2016 Jul;70(1):45-53. doi: 10.1016/j.eururo.2015.04.039. Epub 2015 May 16.
4
Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates.癌性前列腺组织学良性区域中PCA3和TMPRSS2-ERG表达的改变:对五个前列腺组织进行的系统定量mRNA分析
BMC Urol. 2015 Aug 21;15:88. doi: 10.1186/s12894-015-0077-7.
5
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.用于前列腺癌早期检测的尿液第一代多重生物标志物分析。
Cancer Res. 2008 Feb 1;68(3):645-9. doi: 10.1158/0008-5472.CAN-07-3224.
6
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.主动监测队列中的尿 TMPRSS2:ERG 和 PCA3:Canary 前列腺主动监测研究中的基线分析结果。
Clin Cancer Res. 2013 May 1;19(9):2442-50. doi: 10.1158/1078-0432.CCR-12-3283. Epub 2013 Mar 20.
7
Clinical Use of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African-American Men Undergoing Prostate Biopsy.临床应用 PCA3 和 TMPRSS2:ERG 尿生物标志物在接受前列腺活检的非裔美国男性中的应用。
J Urol. 2016 Oct;196(4):1053-60. doi: 10.1016/j.juro.2016.04.075. Epub 2016 Apr 29.
8
Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer.前瞻性多中心研究 PCA3 和 TMPRSS2-ERG 基因融合作为前列腺癌的诊断和预后尿液生物标志物。
Eur Urol. 2014 Mar;65(3):534-42. doi: 10.1016/j.eururo.2012.11.014. Epub 2012 Nov 15.
9
Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden.尿 TMPRSS2:ERG 和 PCA3 与 ERG+和总前列腺癌负担的相关性。
Am J Clin Pathol. 2012 Nov;138(5):685-96. doi: 10.1309/AJCPU7PPWUPYG8OH.
10
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.联合 TMPRSS2:ERG 和 PCA3 RNA 尿检测与侵袭性前列腺癌的检出相关。
JAMA Oncol. 2017 Aug 1;3(8):1085-1093. doi: 10.1001/jamaoncol.2017.0177.

引用本文的文献

1
Evaluation of LncRNAs CBR3-AS1 and PCA3 expression in Gastric cancer and their correlation to clinicopathological variables.长链非编码RNA CBR3-AS1和PCA3在胃癌中的表达及其与临床病理变量的相关性评估。
Genes Cancer. 2025 May 9;16:18-25. doi: 10.18632/genesandcancer.241. eCollection 2025.
2
LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer.LSD1+8a是神经内分泌前列腺癌的一种RNA生物标志物。
Neoplasia. 2025 May;63:101151. doi: 10.1016/j.neo.2025.101151. Epub 2025 Mar 14.
3
Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review).

本文引用的文献

1
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.主动监测队列中的尿 TMPRSS2:ERG 和 PCA3:Canary 前列腺主动监测研究中的基线分析结果。
Clin Cancer Res. 2013 May 1;19(9):2442-50. doi: 10.1158/1078-0432.CCR-12-3283. Epub 2013 Mar 20.
2
Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer.比较尿前列腺癌抗原 3 和 TMPRSS2:ERG 基因融合与基于血清 [-2] 前列腺特异性抗原的前列腺健康指数在前列腺癌检测中的应用。
Clin Chem. 2013 Jan;59(1):280-8. doi: 10.1373/clinchem.2012.195560. Epub 2012 Dec 4.
3
内分泌核受体与长非编码 RNA 在癌症中的相互调控(综述)。
Int J Oncol. 2024 Jan;64(1). doi: 10.3892/ijo.2023.5595. Epub 2023 Dec 1.
4
LncRNA LASTR promote lung cancer progression through the miR-137/TGFA/PI3K/AKT axis through integration analysis.通过整合分析,长链非编码RNA LASTR通过miR-137/TGFA/PI3K/AKT轴促进肺癌进展。
J Cancer. 2022 Jan 6;13(4):1086-1096. doi: 10.7150/jca.66067. eCollection 2022.
5
Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer.外泌体作为前列腺癌新一代诊断和治疗工具。
Int J Mol Sci. 2021 Sep 20;22(18):10131. doi: 10.3390/ijms221810131.
6
Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression.转录网络涉及 ERG 和 AR 协调远端同源盒-1 介导的前列腺癌进展。
Nat Commun. 2021 Sep 7;12(1):5325. doi: 10.1038/s41467-021-25623-2.
7
Pseudogene Associated Recurrent Gene Fusion in Prostate Cancer.前列腺癌中假基因相关的基因融合。
Neoplasia. 2019 Oct;21(10):989-1002. doi: 10.1016/j.neo.2019.07.010. Epub 2019 Aug 22.
8
Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma.鉴定和描述与神经母细胞瘤患者总生存率相关的长链非编码 RNA 特征。
Sci Rep. 2019 Mar 26;9(1):5125. doi: 10.1038/s41598-019-41553-y.
9
Rapid Loss of RNA Detection by In Situ Hybridization in Stored Tissue Blocks and Preservation by Cold Storage of Unstained Slides.储存组织块中原位杂交检测RNA的快速丢失及未染色玻片冷藏保存法
Am J Clin Pathol. 2017 Nov 2;148(5):398-415. doi: 10.1093/ajcp/aqx094.
10
Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients.低PCA3表达是局限性前列腺肿瘤分化不良的一个标志物:来自12076例患者的探索性分析。
Oncotarget. 2017 Feb 7;8(31):50804-50813. doi: 10.18632/oncotarget.15133. eCollection 2017 Aug 1.
Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden.尿 TMPRSS2:ERG 和 PCA3 与 ERG+和总前列腺癌负担的相关性。
Am J Clin Pathol. 2012 Nov;138(5):685-96. doi: 10.1309/AJCPU7PPWUPYG8OH.
4
Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies.基于抗体的前列腺核心活检中 ERG 重排的检测,包括诊断具有挑战性的病例:前列腺核心活检中的 ERG 染色。
Arch Pathol Lab Med. 2012 Aug;136(8):935-46. doi: 10.5858/arpa.2011-0424-OA.
5
Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer.尿液 TMPRSS2:ERG 融合转录本与 PCA3 评分、基因分型和生物学特征相结合,与前列腺癌高危男性前列腺活检结果相关。
Prostate. 2013 Feb 15;73(3):242-9. doi: 10.1002/pros.22563. Epub 2012 Jul 20.
6
ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies.原发性和转移性前列腺癌中 ERG 蛋白表达和基因组重排状态的比较研究——两种单克隆抗体的比较。
Prostate Cancer Prostatic Dis. 2012 Jun;15(2):165-9. doi: 10.1038/pcan.2011.67. Epub 2012 Jan 10.
7
Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.前列腺癌抗原 3 在前列腺癌管理中的当代作用。
Eur Urol. 2011 Nov;60(5):1045-54. doi: 10.1016/j.eururo.2011.08.003. Epub 2011 Aug 25.
8
Common gene rearrangements in prostate cancer.前列腺癌的常见基因重排。
J Clin Oncol. 2011 Sep 20;29(27):3659-68. doi: 10.1200/JCO.2011.35.1916. Epub 2011 Aug 22.
9
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.尿液 TMPRSS2:ERG 融合转录本可分层前列腺癌风险在血清 PSA 升高的男性。
Sci Transl Med. 2011 Aug 3;3(94):94ra72. doi: 10.1126/scitranslmed.3001970.
10
ERG gene rearrangement status in prostate cancer detected by immunohistochemistry.免疫组织化学检测前列腺癌中的 ERG 基因重排状态。
Virchows Arch. 2011 Oct;459(4):441-7. doi: 10.1007/s00428-011-1128-4. Epub 2011 Jul 20.